Image

Tart Cherry Juice for Sleep in Older Adults with Insomnia: a Pilot Study of Feasibility and Comprehensive Mechanisms

Tart Cherry Juice for Sleep in Older Adults with Insomnia: a Pilot Study of Feasibility and Comprehensive Mechanisms

Not Recruiting
65 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this research study is test if a study that asks older adults with sleep problems to consume tart cherry products is feasible and determine if it can change sleep patterns. This study is a total of 12 weeks. Participants will be asked to consume tart cherry juice for 4 weeks and the placebo juice for 4 weeks, while wearing a digital monitor that measures sleep. Blood (about 3 teaspoons) and urine (about 2 tablespoons) samples will be taken before and after consuming both juices to measure certain biological markers related to sleep.

Description

The overall goal of this study is to determine feasibility of a tart cherry juice intervention in older adults, and generate preliminary data of outcomes and mechanisms related to sleep. We propose a 2-arm randomized, double-blind, cross-over study in 20 older adults with self-reported insomnia. Participants will consume 240 mL of tart cherry juice or placebo (calorically matched to the tart cherry juice beverage, but theoretically devoid of melatonin, tryptophan, magnesium and flavonoids), twice/evening for 4 weeks in a randomly assigned order.

Eligibility

Inclusion Criteria:

  • Men and women aged ≥65 years
  • Self-reporting insomnia (e.g., trouble sleeping approximately 3 nights a week for at least 6 months and/or an Insomnia Severity Index score ≥ 10 points)
  • Usual bed-time between 8:00 pm and 1:00 am

Exclusion Criteria:

  • Unwilling to follow the study protocol
  • Inability to properly use the wearable device, complete smartphone-based surveys, or follow the intervention protocol
  • Self-report of medically diagnosed sleep disorders except insomnia (e.g., sleep apnea)
  • Current and consistent use of sleep aids or hypnotic prescriptions (e.g., trazadone)
  • Self-report of cognitive impairment, dementia, or other neurological disorder
  • Are on unstable medications (i.e., change within the last 3 months) for other conditions
  • Have an allergy to the intervention products
  • Self-report history of diabetes
  • Current alcohol (Alcohol Use Disorders Identification Test ≥4 points33,34) or drug use disorder (Drug Abuse Screening Test,35,36 DAST-10>2 points)
  • Are excessive caffeine drinkers (>5 cups of caffeinated beverages a day)
  • Any other reason/condition the PI and investigative team believe this intervention would be unsafe

Study details
    Sleep Problems
    Insomnia

NCT06786494

Courtney Millar

5 December 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.